The availability of inhaled human insulin (Exubera) may lead to a great acceptance of insulin therapy in Euopean type 2 diabetes patients failing on diet and/ or oral agent therapy

Research output: Contribution to journalArticle


  • L Blonde
  • M Kvasz
  • N Marchant
  • SA Ross


Original languageEnglish
JournalEASD Copenhagen 14th September 2006
Publication statusPublished - 1 Jan 2007

Sustainable Development Goals